Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Autonomous Analysis of CIBMTR Datasets Using Artificial Intelligence Agents

Jiasheng Wang, Aziz Nazha

Blood (2024) 144 (Supplement 1): 7489.

https://doi.org/10.1182/blood-2024-207380

Published: 2024

Journal Articles

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Qingxiao Chen, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Jing Chen, Xiaoyan Han, Li Yang, Wenjun Wu, YI LI, Donghua He, Jingsong He, Zhen Cai

Blood (2024) 144 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2024-197887

Published: 2024

Journal Articles

Real-World Trends of Cytokine Release Syndrome and Neurologic Events, and Pattern of Their Management Among Patients Receiving Axicabtagene Ciloleucel for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) in the US: A CIBMTR Report

Jiasheng Wang, Shakthi Bhaskar, Babatunde Adedokun, Olalekan O. Oluwole, Leland Metheny, Amy Moskop, Caron A. Jacobson, Geoffrey Shouse, Sairah Ahmed, Armin Ghobadi, Saurabh Dahiya, Jiali Yan, Zhen-Huan Hu, Timothy Best, Jenny J. Kim, Debbie L. Mirjah, Marcelo C. Pasquini, Frederick L. Locke

Blood (2024) 144 (Supplement 1): 527.

https://doi.org/10.1182/blood-2024-209093

Published: 2024

Journal Articles

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Mengmeng Dong, Xiao Xiao, Zhen Cai, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Li Yang, Haimeng Yan

Blood (2024) 144 (Supplement 1): 6894.

https://doi.org/10.1182/blood-2024-210534

Published: 2024

Journal Articles

Management of Acquired Hemophilia a in the Backdrop of Coronavirus Disease 19 and Multiple Myeloma

Zhen Cai, Mengmeng Dong, Jinna Zhang, Jiasheng Wang

Blood (2024) 144 (Supplement 1): 5508.

https://doi.org/10.1182/blood-2024-209916

Published: 2024

Journal Articles

LILRB4 Synthetic T-Cell Receptor and Antigen Receptor-T (STAR-T) for Refractory/Relapsed Acute Myeloid Leukemia: First-in-Human Phase I Clinical Trial

Xiangyu Zhao, Meng Lv, Yu Wang, Yi-Yang Ding, Zhixiao Zhou, Jiasheng Wang, HongLi Zheng, Xueqiang Zhao, Xin Lin, Xiao Jun Huang

Blood (2024) 144 (Supplement 1): 4831.

https://doi.org/10.1182/blood-2024-207297

Published: 2024

Journal Articles

Incidence and Outcomes of Pneumocystis Pneumonia Following Chimeric Antigen Receptor T-Cell Therapy: A Real-World Analysis

Jiasheng Wang, Michael Daunov, Brenda W Cooper

Blood (2023) 142 (Supplement 1): 6897.

https://doi.org/10.1182/blood-2023-190785

Published: 2023

Journal Articles

Social Determinants of Health (SDoH) Scores for Adolescent and Young Adults (AYAs) at a Public Safety-Net Teaching Hospital: A Retrospective Cohort Analysis

Michael Daunov, Katherine Ann Daunov, Jiasheng Wang, John Eric Fisher, Tamila Kindwall-Keller

Blood (2023) 142 (Supplement 1): 7390.

https://doi.org/10.1182/blood-2023-182921

Published: 2023

Journal Articles

The Risk of Cerebrovascular Accident in Patients with Myelodysplastic Syndrome in the United States: A Nationwide Population-Based Study

Dina Elantably, Jiasheng Wang, Abdul Rahman Al Armashi, Nabil El Hage Chehade, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 4065–4066.

https://doi.org/10.1182/blood-2022-165582

Published: 2022

Journal Articles

Racial Disparities in Mortality Trends from Acute Myeloid Leukemia: A Population-Based Study in the United States between 2000 and 2019

Abdul Rahman Al Armashi, Anas Al Zubaidi, Dina Elantably, Jiasheng Wang, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 1438.

https://doi.org/10.1182/blood-2022-171171

Published: 2022

Journal Articles

The Risk of Stroke and Myocardial Infarction in Multiple Myeloma: A Population-Based Study in the United States

Abdul Rahman Al Armashi, Dina Elantably, Jiasheng Wang, Anas Al Zubaidi, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 7226–7227.

https://doi.org/10.1182/blood-2022-166847

Published: 2022

Journal Articles

Retrospective Comparison of Patients with Chronic Lymphocytic Leukemia Receiving BTK Inhibitors Versus Obinutuzumab/Venetoclax As Frontline Therapy

Jiasheng Wang, Srilatha Dasari, Michael Daunov, Kanithra Sekaran, Yeseong Kim, Brenda W. Cooper

Blood (2022) 140 (Supplement 1): 9889–9890.

https://doi.org/10.1182/blood-2022-167875

Published: 2022

Journal Articles

Autoimmune Hemolytic Anemia and Increased Stroke Risk in the United States: A Population-Based Study

Akram Alkrekshi, Jiasheng Wang, Dina Elantably, Abdul Rahman Al Armashi

Blood (2022) 140 (Supplement 1): 2429–2430.

https://doi.org/10.1182/blood-2022-164776

Published: 2022

Journal Articles

Dynamics and Predictive Value of T-Cell Chimerism after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Jiasheng Wang, Benjamin Tomlinson, Ehsan Malek, Leland Metheny, Molly Gallogly, Marcos de Lima, Merle Kolk, Brenda W. Cooper

Blood (2022) 140 (Supplement 1): 12831–12832.

https://doi.org/10.1182/blood-2022-163589

Published: 2022

Journal Articles

Race-Specific Mortality from Multiple Myeloma: A CDC Database Population Study in the United States between 2000 and 2020

Anas Al Zubaidi, Abdul Rahman Al Armashi, Dina Elantably, Jiasheng Wang, Akram Alkrekshi

Blood (2022) 140 (Supplement 1): 10045.

https://doi.org/10.1182/blood-2022-171155

Published: 2022

Journal Articles

Real-World Evidence of Incidence and Outcomes of Aplastic Anemia Following Administration of Immune Checkpoint Inhibitors

Srilatha Dasari, William Tse, Jiasheng Wang

Blood (2022) 140 (Supplement 1): 712–713.

https://doi.org/10.1182/blood-2022-168353

Published: 2022

Journal Articles

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Leland Metheny, Ronald M. Sobecks, Christina Cho, Jiasheng Wang, Lisa Ciarrone, Paolo F. Caimi, Folashade Otegbeye, Brenda W. Cooper, Molly Gallogly, Ehsan Malek, Aaron T. Gerds, Betty K. Hamilton, Sergio A Giralt, Miguel-Angel Perales, Marcos J.G. de Lima

Blood (2022) 140 (Supplement 1): 1887–1889.

https://doi.org/10.1182/blood-2022-169935

Published: 2022

Journal Articles

Response Kinetics of Daratumumab-Based Regimens in Patients with Newly Diagnosed or Refractory/Relapsed Multiple Myeloma

Jiasheng Wang, Raul Arroyo-Suarez, William Tse

Blood (2021) 138 (Supplement 1): 3806.

https://doi.org/10.1182/blood-2021-149315

Published: 2021

Journal Articles

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

Xian Zhang, MD, Jiasheng Wang, Yue Liu, Junfang Yang, Jingjing Li, Gailing Zhang, MD, Yanze Shi, Jiujiang He, Dan Song, Wenqian Li, Shulian Xia, Min Zhang, Zhixiao Zhou, Lemei Jia, Hongli Zheng, Xin Lin, Peihua Lu, MD

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-136833

Published: 2020

Journal Articles

Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay

Jiasheng Wang, MD, Kirsten M Boughan, DO, Paolo F Caimi, MD, Brenda Cooper, MD, Marcos de Lima, MD, Molly M Gallogly, MD PhD, Ehsan Malek, MD, Leland Metheny, III, MD, Folashade Otegbeye, MBBChir,MPH, Shufen Cao, Pingfu Fu, PhD, Benjamin Tomlinson, MD

Blood (2019) 134 (Supplement_1): 2607.

https://doi.org/10.1182/blood-2019-131293

Published: 2019

NARROW

Autonomous Analysis of CIBMTR Datasets Using Artificial Intelligence Agents

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Real-World Trends of Cytokine Release Syndrome and Neurologic Events, and Pattern of Their Management Among Patients Receiving Axicabtagene Ciloleucel for Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) in the US: A CIBMTR Report

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Management of Acquired Hemophilia a in the Backdrop of Coronavirus Disease 19 and Multiple Myeloma

LILRB4 Synthetic T-Cell Receptor and Antigen Receptor-T (STAR-T) for Refractory/Relapsed Acute Myeloid Leukemia: First-in-Human Phase I Clinical Trial

Incidence and Outcomes of Pneumocystis Pneumonia Following Chimeric Antigen Receptor T-Cell Therapy: A Real-World Analysis

Social Determinants of Health (SDoH) Scores for Adolescent and Young Adults (AYAs) at a Public Safety-Net Teaching Hospital: A Retrospective Cohort Analysis

The Risk of Cerebrovascular Accident in Patients with Myelodysplastic Syndrome in the United States: A Nationwide Population-Based Study

Racial Disparities in Mortality Trends from Acute Myeloid Leukemia: A Population-Based Study in the United States between 2000 and 2019

The Risk of Stroke and Myocardial Infarction in Multiple Myeloma: A Population-Based Study in the United States

Retrospective Comparison of Patients with Chronic Lymphocytic Leukemia Receiving BTK Inhibitors Versus Obinutuzumab/Venetoclax As Frontline Therapy

Autoimmune Hemolytic Anemia and Increased Stroke Risk in the United States: A Population-Based Study

Dynamics and Predictive Value of T-Cell Chimerism after Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

Race-Specific Mortality from Multiple Myeloma: A CDC Database Population Study in the United States between 2000 and 2020

Real-World Evidence of Incidence and Outcomes of Aplastic Anemia Following Administration of Immune Checkpoint Inhibitors

Multicenter Phase I Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Response Kinetics of Daratumumab-Based Regimens in Patients with Newly Diagnosed or Refractory/Relapsed Multiple Myeloma

A Feasibility and Safety Study of a Novel CD19-Directed Synthetic T-Cell Receptor and Antigen Receptor (STAR) T-Cell Therapy for Refractory and Relapsed (R/R) B Cell Acute Lymphoblastic Leukemia (B-ALL)

Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only